2022-RA-1689-ESGO Should immunotherapy be included as first-line adjuvant treatment in high-risk vulvar melanomas?
| Autor: | Virginia Benito, Cristina Molo, Amina Lubrano, Pino García, Uriel Bohn |
|---|---|
| Rok vydání: | 2022 |
| Zdroj: | Vaginal and vulvar cancer. |
| DOI: | 10.1136/ijgc-2022-esgo.975 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|